Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 40 | 2024 | 1516 | 2.550 |
Why?
|
| Pregnancy Complications | 10 | 2024 | 193 | 2.420 |
Why?
|
| Gynecology | 3 | 2024 | 23 | 2.300 |
Why?
|
| Obesity | 13 | 2024 | 855 | 1.990 |
Why?
|
| Weight Gain | 10 | 2016 | 181 | 1.730 |
Why?
|
| Prenatal Care | 5 | 2020 | 134 | 1.460 |
Why?
|
| Pregnancy Outcome | 11 | 2024 | 159 | 1.460 |
Why?
|
| Diabetes, Gestational | 10 | 2021 | 339 | 1.430 |
Why?
|
| Menopause | 6 | 2024 | 72 | 1.400 |
Why?
|
| Female | 54 | 2024 | 13136 | 1.280 |
Why?
|
| Humans | 56 | 2024 | 18430 | 1.140 |
Why?
|
| Mass Screening | 9 | 2021 | 690 | 1.120 |
Why?
|
| Adult | 35 | 2024 | 7910 | 1.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2023 | 41 | 0.980 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2024 | 59 | 0.960 |
Why?
|
| Obstetrics | 1 | 2024 | 23 | 0.920 |
Why?
|
| Internship and Residency | 1 | 2024 | 50 | 0.900 |
Why?
|
| Health Services | 3 | 2020 | 117 | 0.890 |
Why?
|
| Blood Pressure Determination | 1 | 2023 | 58 | 0.890 |
Why?
|
| Postpartum Period | 4 | 2013 | 93 | 0.840 |
Why?
|
| Young Adult | 15 | 2024 | 2518 | 0.800 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 95 | 0.790 |
Why?
|
| Infant, Newborn | 12 | 2024 | 872 | 0.790 |
Why?
|
| Glucose Tolerance Test | 8 | 2021 | 106 | 0.740 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.730 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.730 |
Why?
|
| Urologic Diseases | 1 | 2020 | 8 | 0.730 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 70 | 0.690 |
Why?
|
| Fractures, Bone | 4 | 2012 | 91 | 0.680 |
Why?
|
| Premature Birth | 5 | 2024 | 138 | 0.660 |
Why?
|
| Fetal Macrosomia | 5 | 2021 | 27 | 0.650 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 60 | 0.650 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 350 | 0.650 |
Why?
|
| Medicaid | 2 | 2020 | 211 | 0.650 |
Why?
|
| Retrospective Studies | 10 | 2024 | 2550 | 0.620 |
Why?
|
| Blood Glucose | 2 | 2021 | 346 | 0.610 |
Why?
|
| Managed Care Programs | 1 | 2020 | 347 | 0.600 |
Why?
|
| Counseling | 2 | 2016 | 197 | 0.590 |
Why?
|
| Health Care Costs | 1 | 2020 | 251 | 0.590 |
Why?
|
| Primary Health Care | 2 | 2020 | 848 | 0.560 |
Why?
|
| Postnatal Care | 1 | 2016 | 22 | 0.560 |
Why?
|
| Ovariectomy | 3 | 2012 | 9 | 0.530 |
Why?
|
| Cohort Studies | 13 | 2023 | 2672 | 0.520 |
Why?
|
| Body Mass Index | 10 | 2024 | 974 | 0.510 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 407 | 0.500 |
Why?
|
| Cervical Intraepithelial Neoplasia | 2 | 2011 | 16 | 0.490 |
Why?
|
| Vaginal Smears | 2 | 2011 | 50 | 0.490 |
Why?
|
| Group Processes | 1 | 2014 | 12 | 0.490 |
Why?
|
| Vaccination | 6 | 2024 | 674 | 0.470 |
Why?
|
| Hospitalization | 1 | 2020 | 847 | 0.470 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2011 | 127 | 0.440 |
Why?
|
| United States | 10 | 2024 | 4164 | 0.430 |
Why?
|
| Menopause, Premature | 1 | 2012 | 4 | 0.420 |
Why?
|
| Carpal Bones | 1 | 2012 | 3 | 0.420 |
Why?
|
| Exercise Therapy | 2 | 2015 | 74 | 0.410 |
Why?
|
| Diet Therapy | 1 | 2012 | 12 | 0.410 |
Why?
|
| Insulin | 1 | 2013 | 208 | 0.410 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 26 | 0.410 |
Why?
|
| Guideline Adherence | 1 | 2013 | 162 | 0.400 |
Why?
|
| Papanicolaou Test | 1 | 2011 | 38 | 0.400 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 288 | 0.360 |
Why?
|
| Gestational Age | 6 | 2016 | 119 | 0.360 |
Why?
|
| Treatment Outcome | 5 | 2020 | 1296 | 0.350 |
Why?
|
| Infant | 7 | 2023 | 1245 | 0.320 |
Why?
|
| Affect | 1 | 2007 | 26 | 0.300 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 39 | 0.280 |
Why?
|
| Women's Health | 1 | 2007 | 207 | 0.280 |
Why?
|
| Mental Health | 1 | 2007 | 168 | 0.270 |
Why?
|
| Middle Aged | 10 | 2024 | 8284 | 0.270 |
Why?
|
| Logistic Models | 4 | 2013 | 962 | 0.260 |
Why?
|
| Body Weight | 3 | 2016 | 223 | 0.260 |
Why?
|
| Adolescent | 10 | 2024 | 3798 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 142 | 0.260 |
Why?
|
| Mothers | 2 | 2016 | 110 | 0.260 |
Why?
|
| Preconception Care | 2 | 2016 | 48 | 0.250 |
Why?
|
| Weight Loss | 2 | 2020 | 321 | 0.250 |
Why?
|
| Washington | 4 | 2020 | 388 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 760 | 0.250 |
Why?
|
| Osteoporosis | 2 | 2011 | 76 | 0.240 |
Why?
|
| Risk Factors | 9 | 2021 | 3449 | 0.240 |
Why?
|
| Stillbirth | 1 | 2024 | 30 | 0.240 |
Why?
|
| Quality of Life | 2 | 2023 | 529 | 0.230 |
Why?
|
| Curriculum | 1 | 2024 | 40 | 0.230 |
Why?
|
| Oregon | 3 | 2020 | 222 | 0.230 |
Why?
|
| Organ Size | 2 | 2021 | 16 | 0.230 |
Why?
|
| Infant, Premature | 2 | 2022 | 60 | 0.230 |
Why?
|
| Diet | 2 | 2016 | 371 | 0.220 |
Why?
|
| Precision Medicine | 1 | 2023 | 29 | 0.220 |
Why?
|
| Clinical Competence | 1 | 2024 | 108 | 0.220 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 15 | 0.220 |
Why?
|
| Adipose Tissue | 1 | 2023 | 60 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 530 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2023 | 1314 | 0.210 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 52 | 0.210 |
Why?
|
| Lipids | 1 | 2023 | 78 | 0.210 |
Why?
|
| Granulosa Cell Tumor | 1 | 2002 | 1 | 0.210 |
Why?
|
| Advisory Committees | 1 | 2023 | 112 | 0.210 |
Why?
|
| Liver | 1 | 2021 | 33 | 0.200 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 50 | 0.200 |
Why?
|
| Thinness | 3 | 2016 | 29 | 0.200 |
Why?
|
| Hip Fractures | 2 | 2012 | 68 | 0.190 |
Why?
|
| Papillomaviridae | 2 | 2011 | 53 | 0.190 |
Why?
|
| Odds Ratio | 4 | 2011 | 701 | 0.190 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 116 | 0.190 |
Why?
|
| Aspirin | 1 | 2021 | 67 | 0.190 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 38 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 68 | 0.190 |
Why?
|
| Pregnant Women | 1 | 2021 | 44 | 0.190 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 45 | 0.190 |
Why?
|
| Cost of Illness | 2 | 2020 | 100 | 0.180 |
Why?
|
| Syndrome | 1 | 2020 | 29 | 0.180 |
Why?
|
| Incidence | 3 | 2021 | 1314 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 249 | 0.170 |
Why?
|
| Morbidity | 1 | 2020 | 62 | 0.170 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.170 |
Why?
|
| Papillomavirus Infections | 2 | 2011 | 136 | 0.170 |
Why?
|
| Attitude | 1 | 2019 | 33 | 0.170 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 18 | 0.170 |
Why?
|
| Anxiety | 2 | 2013 | 156 | 0.170 |
Why?
|
| Prognosis | 2 | 2019 | 624 | 0.170 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 45 | 0.160 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2008 | 1 | 0.160 |
Why?
|
| Polysomnography | 1 | 2008 | 5 | 0.160 |
Why?
|
| Wrist | 1 | 2008 | 2 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 8 | 0.160 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 321 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 120 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2008 | 38 | 0.160 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 130 | 0.160 |
Why?
|
| Clinical Protocols | 2 | 2019 | 45 | 0.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 11 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 333 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 21 | 0.130 |
Why?
|
| Overweight | 4 | 2024 | 276 | 0.130 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2024 | 17 | 0.120 |
Why?
|
| Pediatric Obesity | 1 | 2016 | 80 | 0.120 |
Why?
|
| Cesarean Section, Repeat | 1 | 2014 | 2 | 0.120 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 2 | 0.120 |
Why?
|
| Pamphlets | 1 | 2014 | 8 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 743 | 0.120 |
Why?
|
| Aged | 6 | 2012 | 6417 | 0.120 |
Why?
|
| Confidence Intervals | 2 | 2014 | 253 | 0.120 |
Why?
|
| Research Design | 2 | 2019 | 402 | 0.120 |
Why?
|
| Self-Help Groups | 1 | 2014 | 32 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 159 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2022 | 1143 | 0.120 |
Why?
|
| Energy Intake | 1 | 2014 | 103 | 0.120 |
Why?
|
| Aging | 2 | 2005 | 165 | 0.120 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2012 | 104 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 177 | 0.110 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 1 | 0.110 |
Why?
|
| Infant Care | 1 | 2013 | 6 | 0.110 |
Why?
|
| Life Style | 1 | 2015 | 342 | 0.110 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 18 | 0.110 |
Why?
|
| Asthma | 1 | 2016 | 390 | 0.100 |
Why?
|
| Term Birth | 1 | 2012 | 8 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 23 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 93 | 0.100 |
Why?
|
| Child Health Services | 1 | 2013 | 129 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2012 | 12 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 160 | 0.100 |
Why?
|
| Male | 7 | 2023 | 10440 | 0.100 |
Why?
|
| Remission, Spontaneous | 1 | 2011 | 7 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 150 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2012 | 120 | 0.100 |
Why?
|
| Body Height | 1 | 2012 | 62 | 0.100 |
Why?
|
| Comorbidity | 2 | 2008 | 619 | 0.100 |
Why?
|
| World Health Organization | 1 | 2011 | 15 | 0.100 |
Why?
|
| Models, Biological | 1 | 2011 | 32 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 342 | 0.100 |
Why?
|
| Health Maintenance Organizations | 1 | 2013 | 479 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 43 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 327 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 526 | 0.080 |
Why?
|
| Hot Flashes | 2 | 2006 | 39 | 0.080 |
Why?
|
| Depression | 2 | 2008 | 518 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 965 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 444 | 0.080 |
Why?
|
| Perimenopause | 1 | 2007 | 11 | 0.080 |
Why?
|
| Premenopause | 1 | 2007 | 27 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 36 | 0.080 |
Why?
|
| Causality | 1 | 2007 | 43 | 0.080 |
Why?
|
| Psychometrics | 1 | 2007 | 124 | 0.070 |
Why?
|
| Time Factors | 3 | 2020 | 1136 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 2003 | 0.060 |
Why?
|
| Live Birth | 1 | 2024 | 9 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 26 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 47 | 0.060 |
Why?
|
| Consensus | 1 | 2023 | 41 | 0.060 |
Why?
|
| Child | 2 | 2024 | 2571 | 0.060 |
Why?
|
| Maternal Age | 1 | 2023 | 80 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2023 | 80 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 16 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 1269 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2002 | 30 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2023 | 195 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 3 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2021 | 3 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 6 | 0.050 |
Why?
|
| Parturition | 1 | 2021 | 10 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2021 | 20 | 0.050 |
Why?
|
| Length of Stay | 2 | 2013 | 183 | 0.050 |
Why?
|
| Perinatal Death | 1 | 2021 | 2 | 0.050 |
Why?
|
| Postpartum Hemorrhage | 1 | 2021 | 4 | 0.050 |
Why?
|
| Glucose | 1 | 2021 | 30 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2016 | 1478 | 0.050 |
Why?
|
| Patient Safety | 1 | 2022 | 41 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1173 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 673 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 29 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 911 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1360 | 0.040 |
Why?
|
| Bone Density | 2 | 2011 | 96 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 26 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2015 | 27 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 567 | 0.030 |
Why?
|
| Trial of Labor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 747 | 0.030 |
Why?
|
| Patient Preference | 1 | 2014 | 45 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 1993 | 1 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 1993 | 2 | 0.030 |
Why?
|
| Reaction Time | 1 | 1993 | 3 | 0.030 |
Why?
|
| Electroencephalography | 1 | 1993 | 4 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1993 | 11 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 554 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1993 | 167 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 374 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 319 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2012 | 30 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2012 | 34 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 9 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 162 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 382 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2008 | 4 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2008 | 3 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2008 | 93 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Trifolium | 1 | 2006 | 2 | 0.020 |
Why?
|
| Clonidine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Soybeans | 1 | 2006 | 4 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Amines | 1 | 2006 | 5 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 5 | 0.020 |
Why?
|
| Isoflavones | 1 | 2006 | 14 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2006 | 14 | 0.020 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2006 | 74 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 4 | 0.020 |
Why?
|
| Testosterone | 1 | 2004 | 22 | 0.020 |
Why?
|
| Estradiol | 1 | 2004 | 24 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 44 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 162 | 0.020 |
Why?
|
| Research | 1 | 2005 | 73 | 0.020 |
Why?
|
| Postmenopause | 1 | 2004 | 267 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 552 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 598 | 0.010 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->